Tag: Insmed Incorporated

Finance

Investors Are Watching : Halliburton Company (NYSE:HAL), Insmed (NASDAQ:INSM), FactSet Research Systems (NYSE:FDS), Keurig Green Mountain, Inc. (NASDAQ:GMCR), Great Panther (NYSEMKT:GPL)

Halliburton Company (NYSE:HAL)‘s stock had its “neutral” rating reaffirmed by Zacks in a note issued to investors on Friday. They currently have a $71.00 target price on the stock. Zacks‘s target price indicates a potential upside of 5.01% from the stock’s previous close. Halliburton Company (NYSE:HAL) belongs to Basic Materials sector. Its net profit margin is 9.50% and weekly performance is 0.21%. On last trading … Continue reading Investors Are Watching : Halliburton Company (NYSE:HAL), Insmed (NASDAQ:INSM), FactSet Research Systems (NYSE:FDS), Keurig Green Mountain, Inc. (NASDAQ:GMCR), Great Panther (NYSEMKT:GPL)

Colin Pettis
Finance

Hot Biotech Movers: Chelsea Therapeutics International Ltd. (NASDAQ:CHTP), Insmed Incorporated (NASDAQ:INSM), Gilead Sciences, Inc. (NASDAQ:GILD), Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA), MannKind Corporation (NASDAQ:MNKD)

Chelsea Therapeutics International Ltd. (NASDAQ:CHTP) saw a significant decrease in short interest during the month of May. As of May 30th, there was short interest totalling 8,284,614 shares, a decrease of 15.5% from the May 15th total of 9,799,100 shares. Several analysts have recently commented on the stock. Analysts at Roth Capital downgraded shares of Chelsea Therapeutics International from a “buy” rating to a “neutral” … Continue reading Hot Biotech Movers: Chelsea Therapeutics International Ltd. (NASDAQ:CHTP), Insmed Incorporated (NASDAQ:INSM), Gilead Sciences, Inc. (NASDAQ:GILD), Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA), MannKind Corporation (NASDAQ:MNKD)

Kristen Barton